Home NDC 0469-0125 Xtandi
Product NDC 0469-0125
11-digit product format 004690125
Labeler code 0469
Product ID 0469-0125_1cc0ed2a-2c33-4027-90bb-572d717b81d2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name enzalutamide
Dosage form CAPSULE
Route ORAL
Labeler Astellas Pharma US, Inc.
Application NDA203415
Marketing category NDA
Marketing start 2012-08-31
Substance ENZALUTAMIDE
Active strength 40 mg/1
Pharmacologic classes Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N203415-001 XTANDI ENZALUTAMIDE 40MG CAPSULE / ORAL RLD, RS 2012-08-31
Orange Book patents# Current patent rows page 1 of 1 · 14 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N203415-001 I-926 2026-11-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 c2088c7a36db…2026-09-14 22:38:34 2026-08 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 3bdfa0b2c4d7…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 11 · 434 observed states.
Observed Orange Book exclusivity history# Exclusivity history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2022-10-28 04:53 UTC 2022-10 N203415-001 I-808 2022-12-16 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N203415-001 I-808 2022-12-16 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N203415-001 I-808 2022-12-16 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N203415-001 I-926 2026-11-17 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Xtandi
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ENZALUTAMIDE 40 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 93T0T9GKNU Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 6 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1307303 Internal RxNorm lookup 1307309 Internal RxNorm lookup 2390644 Internal RxNorm lookup 2390646 Internal RxNorm lookup 2390648 Internal RxNorm lookup 2390650 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0469-0125-99 Xtandi 1 in 1 CARTON CAPSULE 1 22 0469-0125-99 Xtandi 120 in 1 BOTTLE CAPSULE 120 22
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0469-0125 XTANDI (ENZALUTAMIDE) CAPSULE XTANDI (ENZALUTAMIDE) TABLET [ASTELLAS PHARMA US, INC.] 21 Current NDC, Legacy NDC, 2 package rows 20250406_b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0469-0125-99 00469012599 1 BOTTLE in 1 CARTON (0469-0125-99) / 120 CAPSULE in 1 BOTTLE 1 bottle 2012-08-31 0000-00-00 No No Current